HMGB1 and Sepsis: If HMGB1 is considered a strong pro-inflammatory cytokine involved in the pro-inflammatory phase of SIRS/sepsis, it could be hypothesised that lower levels could be observed when the patient with severe sepsis/septic shock moves from a pro-inflammatory state to a state with immune paresis.